Cours ProtoKinetix, Incorporated Other OTC
Actions
PKTX
US7437221002
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 6,58 M 5,98 M |
---|---|---|---|---|---|
Résultat net 2022 | -1 M -909 k | Résultat net 2023 | - 0 | VE / CA 2022 | - |
Trésorerie nette 2022 | 25,55 k 23,23 k | Trésorerie nette 2023 | 20,41 k 18,56 k | VE / CA 2023 | - |
PER 2022 |
-4,29
x | PER 2023 |
-1,9
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 60,78% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Clarence Smith
CEO | Chief Executive Officer | 60 | 01/06/14 |
Michael Guzzetta
DFI | Director of Finance/CFO | 66 | 14/11/17 |
Victoria Bantz
LAW | General Counsel | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Clarence Smith
CEO | Chief Executive Officer | 60 | 01/06/14 |
Edward McDonough
BRD | Director/Board Member | 71 | 01/07/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+41,79% | 54,04 Md | |
-0,56% | 41,92 Md | |
+46,90% | 41,96 Md | |
-7,20% | 28,35 Md | |
+12,59% | 26,35 Md | |
-21,51% | 19 Md | |
+6,92% | 13 Md | |
+24,91% | 12,19 Md | |
+29,60% | 12,28 Md |